Last week, as I walked out of a successful embryo transfer procedure, I felt a familiar rush of satisfaction. This wasn’t just about the science or the precision of the medical process — it was about the potential for a new beginning. A few hours later, in a different setting, I listened to a founder pitch their startup with the same sense of anticipation. In my world, a successful IVF cycle and a winning startup pitch aren’t that different. They both hinge on a combination of hope, meticulous preparation, and the ability to see what others might overlook.
In both arenas, the stakes are incredibly high. For a couple undergoing IVF, the dream of starting a family rests on a complex interplay of biology, timing, and technology. For a startup founder, their vision of building a transformative company rests on their ability to convince investors of their potential. Each successful cycle and pitch is a testament to the grit and resilience it takes to navigate uncertainty and turn a vision into reality.
When I first became involved in angel investing, I was struck by the parallels between the two fields. In both, there’s an initial moment of excitement, followed by a period of intense scrutiny and assessment. Just as I evaluate the viability of an embryo, I assess the viability of a startup. Does the team have the right mix of skills? Is the market opportunity compelling? Is there evidence of traction? In both cases, I’m looking for signs of life — indicators that the venture has the potential to grow and thrive.
One of the most memorable startup pitches I encountered was from a founder who had endured several setbacks. Much like the many patients I’ve seen who have faced failed IVF cycles, this founder had learned from each failure, refining their approach and strategy. Their persistence paid off, and they ultimately secured funding. Similarly, many of my IVF patients have faced multiple rounds of treatment, each time gaining more insights and resilience. It’s the same tenacity that fuels both journeys — an unwavering belief in the possibility of success despite the odds.
The lesson I draw from both IVF and investing is simple yet profound: success often comes to those who are prepared to embrace failure as part of the journey. It’s not about avoiding mistakes but about learning from them. In IVF, a failed cycle provides invaluable information that can inform future treatments. In startups, a pivot or a failed product launch can be the catalyst for innovation and growth.
Another striking similarity between IVF and startups is the importance of timing. In IVF, the timing of hormone injections, egg retrieval, and embryo transfer is critical. A misstep in the schedule can jeopardize the entire cycle. Startups, too, must be acutely aware of timing. Launching a product too early or too late can mean the difference between success and failure. Understanding the market dynamics, anticipating trends, and being ready to act decisively are skills that both IVF specialists and startup founders must master.
The role of storytelling in both fields cannot be understated. In the startup world, a compelling narrative can turn a skeptical investor into a believer. It’s not just about presenting data and projections; it’s about painting a picture of the future and inviting others to be part of that journey. In IVF, I find that sharing stories of previous patients, especially those who faced similar struggles, can offer hope and reassurance. These stories become a beacon for others, illuminating the path forward.
While facts and figures are crucial, they must be woven into a larger narrative that resonates on an emotional level. Just as I guide my patients through the emotional highs and lows of IVF, a startup pitch must guide investors through the journey — from identifying the problem to envisioning the solution and the impact it will have.
In both IVF and startups, there’s an inherent unpredictability that must be embraced. No matter how well-prepared or experienced you are, there are factors beyond your control. A change in regulations, a shift in market demand, or a biological anomaly can alter the course of events. Accepting this uncertainty and remaining adaptable is a skill that serves well in both domains.
To those who ask me why I continue to straddle the worlds of IVF and angel investing, my answer is simple: both are about creating life and nurturing potential. Whether it’s the potential of an embryo or the potential of a nascent business, both require a delicate balance of science, art, and faith.
In the end, what keeps me invested in both fields is the privilege of witnessing transformation. Every successful IVF cycle and every thriving startup is a testament to human ingenuity and perseverance. It’s a reminder that with the right mix of passion, preparation, and patience, we can turn dreams into reality.
The next time I walk into an embryo transfer or listen to a startup pitch, I’ll carry with me the lessons learned from both. Because, at the heart of it, whether in a lab or a boardroom, we’re all striving to bring something new into the world and watch it grow.